Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Abbisko Teams Up With Lilly In Latest U.S.-China Pharma Collaboration
David Ricks, chief executive officer of Eli Lilly & Co., speaks during the China Development Forum in Beijing in March this year. Photographer: Qilai Shen/Bloomberg © 2026 Bloomberg Finance LP In the latest China pharmaceutical industry…
3 Under-the-Radar Biotech Takeover Targets for the Next Pharma Buying Spree
Large-cap pharma is back in the deal market. AbbVie's (NASDAQ: ABBV | ABBV Price Prediction) pending acquisition of Apogee Therapeutics signaled that big buyers will pay up for de-risked clinical assets. Patent cliffs approach, GLP-1 franchises…
ARS Pharmaceuticals (SPRY) Stock Sinks After-Hours After Commercial Update On Neffy Coverage - ARS Pharma
ARS Pharmaceuticals, Inc. (NASDAQ:) shares fell in after-hours trading on Wednesday after the company provided commercial and financial updates, including no new formulary additions for Neffy in the July 2026 coverage cycle. SPRY closed Wednesday's…
Swiss healthcare costs rise faster than patients can keep up
Switzerland's mandatory health insurance premiums reached CHF423 ($470) monthly in 2024 – 7% of disposable income, up from 4% in 2004. Parliament approved 16 cost-containment measures in March 2025, but a referendum capping premiums at 10%…
Merck KGaA Agrees on $11.3 Billion Purchase of Bio-Techne
Merck KGaA agreed to buy Bio-Techne Corporation for $11.3 billion to bolster its life-science business, marking the German pharma and technology group's biggest acquisition in more than a decade. Merck agreed to pay $73 per share in cash for the US…
Inside the Lilly CEO's Plan to Build on Its $1 Trillion Weight-Loss Empire
This article is for subscribers only. Welcome back to Bloomberg's Health Monitor, a weekly look at the boardroom decisions, scientific advances and policy fights shaping the future of medicine. Sign up now if you're not already on the list. Lilly's…
Germany's Merck boosts life sciences business with $11 billion Bio-Techne deal
Arne Dedert | Picture Alliance | Getty Images German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, expanding its presence in the life sciences market. Shares of Bio-Techne rose 22% in…
Sanofi: Dupixent Risks Overstated, Valuation Disconnect Creates Opportunity (NASDAQ:SNY)
Sanofi is reiterated as a compelling buy, trading at a pronounced valuation discount versus pharma peers despite solid results and strategic focus. Dupixent drives 40% of Sanofi's sales and 80% of Q1 incremental growth; management is pursuing…
Is GSK Quietly Becoming An Oncology Powerhouse (NYSE:GSK)
GSK's dividend yield is 3.46%, which is higher than most Big Pharma players. GSK reaffirmed that its core earnings per share growth will be between 7% and 9% in 2026. In addition to the strong performance of its blockbusters, Nucala, Dovato, and…
America on the Ropes
Dear Readers, our politicians don't rile us up against “foreign enemies,” Russians, Iranians, Chinese, and “Muslim terrorists”–Osama bin Laden in Afghanistan, Saddam Hussein in Iraq, Gadaffi in Libya, Assad in…
Stock Market Today: Why sensex, nifty opened higher as crude slipped near $70 | Dynamite News
Post Published By: Donika Singh Updated: 25 June 2026, 9:46 AM IST New Delhi: Indian stock markets opened higher on Thursday as crude oil prices eased towards the $70-per-barrel mark, with tankers resuming their exit from the Strait of Hormuz…
Cursor Deal Puts US On Track For Record Startup M&A Year
When someone spends $60 billion to buy a startup, M&A spending suddenly starts looking pretty robust. Those were the unsurprising findings of a Crunchbase analysis of U.S. startup acquisition outlays in 2026. So far this year, acquirers have spent…
An Analyst Just Declared Eli Lilly the 'Clear Winner' of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right?
In the eyes of Wall Street, Eli Lilly (LLY +2.19%) continues to cement its lead over the competition in the field of weight-loss and diabetes drugs. After revealing a pair of positive developments coinciding with the American Diabetes Association's…
SETL Expands Into AI Datacenter Engineering With Strategic GScale Energy Acquisition
Hyderabad-based SETL has strategically acquired a majority stake in GScale Energy, committing Rs 500 crore to expand its precision engineering expertise into the burgeoning AI Datacenter infrastructure market, powering India's digital future. SETL…
Galectin De-Risks Belapectin Path With FDA Alignment - Sets Stage For Phase 3 Upside
Galectin Therapeutics remains a buy as recent FDA alignment de-risks belapectin's Phase 3 path and clarifies regulatory endpoints. The FDA's endorsement of a single, well-controlled Phase 3 trial with a composite clinical outcome endpoint reduces…
Receive a Daily briefing on Pharma Industry News
Get Started